These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32324041)

  • 1. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing.
    Pandey P; Setya D; Srivastava R; Singh MK
    Immunohematology; 2020 Jan; 36(1):19-28. PubMed ID: 32324041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter prospective observational study on the use of type and screen method versus conventional type and crossmatch policy for pre-transfusion testing in the Indian population.
    Mathur A; Jindal A; Tiwari AK; Bhuyan D; Jagannathan L; Sawant RB; Basu S; Reddy M; Datta SS
    Immunohematology; 2022 Sep; 38(3):100-105. PubMed ID: 36190198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Gupta GK; Raina V
    Asian J Transfus Sci; 2017; 11(1):40-44. PubMed ID: 28316439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing.
    Heddle NM; O'Hoski P; Singer J; McBride JA; Ali MA; Kelton JG
    Br J Haematol; 1992 Aug; 81(4):579-84. PubMed ID: 1390245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.
    Thakral B; Saluja K; Sharma RR; Marwaha N
    Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretransfusion testing without serologic crossmatch: approaches to ensure patient safety.
    Kuriyan M; Fox E
    Vox Sang; 2000; 78(2):113-8. PubMed ID: 10765147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type and screen method and Coombs crossmatch method for pretransfusion testing: A prospective comparative study in a tertiary care hospital in Delhi.
    Anu KD; Pahuja S; Sharma G
    Asian J Transfus Sci; 2022; 16(1):83-88. PubMed ID: 36199420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of type and screen policy: Perspective from a developing country!
    Aggarwal G; Tiwari AK; Arora D; Dara RC; Acharya DP; Bhardwaj G; Sharma J
    Asian J Transfus Sci; 2018; 12(1):42-45. PubMed ID: 29563674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a manual hexadimethrine bromide-antiglobulin test with saline- and albumin-antiglobulin tests for pretransfusion testing.
    Mintz PD; Anderson G
    Transfusion; 1987; 27(2):134-7. PubMed ID: 3824470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transfusion management of patients with red blood cell antibodies].
    Bujandrić NB; Grujić JN; Krga-Milanović MM
    Med Pregl; 2013; 66(11-12):491-6. PubMed ID: 24575638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching.
    Pinkerton PH; Coovadia AS; Goldstein J
    Transfusion; 1992; 32(9):814-7. PubMed ID: 1471244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substitution of the "group-and-screen" for the full crossmatch in elective operations.
    Kelton JG; Perrault RA; Blajchman MA
    Can Anaesth Soc J; 1983 Nov; 30(6):641-5. PubMed ID: 6640401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India.
    Pathak S; Chandrashekhar M; Wankhede GR
    Asian J Transfus Sci; 2011 Jul; 5(2):153-6. PubMed ID: 21897595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with the routine use of an abbreviated crossmatch.
    Shulman IA; Nelson JM; Saxena S; Thompson JC; Okamoto M; Kent DR; Nakayama RK
    Am J Clin Pathol; 1984 Aug; 82(2):178-81. PubMed ID: 6465079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative utility of the autologous control and the antiglobulin test phase of the crossmatch.
    Perkins JT; Arruza M; Fong K; Sosler SD; Saporito C
    Transfusion; 1990; 30(6):503-7. PubMed ID: 2378021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic verification of donor-recipient compatibility: the computer crossmatch.
    Butch SH; Judd WJ; Steiner EA; Stoe M; Oberman HA
    Transfusion; 1994 Feb; 34(2):105-9. PubMed ID: 8310478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with autoantibodies or clinically insignificant alloantibodies require an indirect antiglobulin test crossmatch?
    Lee E; Redman M; Burgess G; Win N
    Transfusion; 2007 Jul; 47(7):1290-5. PubMed ID: 17581166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hemolytic reaction implicating Sda antibody missed by immediate spin crossmatch.
    Reznicek MJ; Cordle DG; Strauss RG
    Vox Sang; 1992; 62(3):173-5. PubMed ID: 1609519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.